PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for March 3, 2004 Add to my Yahoo! Subscribe to this News Feed Subscribe to this News Feed   Subscribe to this Podcast Feed PodcastiTunes
 

Baxa Corporation sponsors best practices sessions at the National Home Infusion Association's (NHIA) annual conference on infusion safety, quality management, patient education and effective mentoring

Baxa Corporation announces its sponsorship of presentations on best clinical practices at the National Home Infusion Association's (NHIA) Annual Conference taking place this week (March 1 - 4), at Caesar's Palace in Las Vegas. These Best Practice Presentations focus on infusion safety, quality management, patient education and effective mentoring and will be presented by pharmacy and nursing experts chosen by the NHIA for this conference.

Englewood, CO (PRWEB) March 3, 2004 -- Baxa Corporation announces its sponsorship of presentations on best clinical practices at the National Home Infusion Association's (NHIA) Annual Conference taking place this week (March 1 - 4), at Caesar's Palace in Las Vegas. These Best Practice Presentations focus on infusion safety, quality management, patient education and effective mentoring and will be presented by pharmacy and nursing experts chosen by the NHIA for this conference.

"Baxa has supported best practices throughout its nearly 30-year history," notes CEO Greg Baldwin. "From the beginning, our products have been designed with input from healthcare customers to promote safety and efficiency." Through its Web site and technical publications, Baxa provides best practice recommendations for fluid handling and administration to hospital pharmacists, technicians and nurses.

The sponsorship aligns well with a 2004 Baxa corporate goal to address best practices for patient safety and pharmacy efficiency in its publications, marketing and sales efforts. The company will make an award later this year to a US hospital that exemplifies best practices in pharmacy operations. The award will result from peer nominations and provide grant money and recognition to the chosen hospital. Nominees will be solicited through the Baxa Web site and through its quarterly newsletter.

Baxa Corporation, founded in 1975, is a customer-focused medical device company that provides innovative, solution-based technology for fluid handling and delivery products that promote patient safety.

About Baxa Corporation
As a leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Headquartered in Englewood, Colorado, Baxa has subsidiaries and sales offices in Canada, the United Kingdom, Germany and Denmark; and distribution partners worldwide. Further information is available at http://www.baxa.com.

About National Home Infusion Association
http://www.nhianet.org/index.cfm.

For More Information, Contact:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801 or 303.669.3558
Email: maggie@absolutelypr.com

Other Releases by this Member
OPTIONS
Printer Friendly Printer Friendly Version
Email Email this story to a colleague
CONTACT INFORMATION
Maggie Holben
ABSOLUTELY PUBLIC RELATIONS
303-984-9801
Email us Here
View Our Newsroom
ATTACHED FILES

Greg Baldwin, Chairman/CEO Baxa Corporation
Baldwin says that Baxa has supported best practices throughout its nearly 30-year history.

Baxa Corporation - Englewood, CO
Please do not alter logo in any manner.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.